Clinical Trials
61 trialsBevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
M.D. Anderson Cancer Center
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
Virginia Commonwealth University
Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients
National Cancer Institute, Naples
Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma
Thomas Jefferson University
VICTORIA
National Cancer Institute, Naples
HUVAMER
Haukeland University Hospital
LATENT
AHS Cancer Control Alberta
STING
Leiden University Medical Center
Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma
Virginia Commonwealth University
MC2TCR
Erasmus Medical Center
V-CHANCE
National Cancer Institute, Naples
REVOLUTION
National Cancer Institute, Naples
V-shoRT-R3
National Cancer Institute, Naples
HIT-HGG-2013
University of Göttingen
Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer
State University of New York - Upstate Medical University
Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma
Baylor College of Medicine
VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies
Icahn School of Medicine at Mount Sinai
Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS
Loyola University
Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma
Johns Hopkins University
Study of Valproic Acid (VPA) vs Placebo to Shorten Time of Indwelling Pleural Catheter
M.D. Anderson Cancer Center
Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer
Barbara Ann Karmanos Cancer Institute
Decitabine (DAC) w/ or w/o Valproic Acid (VPA) in Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
M.D. Anderson Cancer Center
Phase I/II Study of Decitabine and Valproic Acid in Relapsed/Refractory Leukemia or Myelodysplastic Syndromes
M.D. Anderson Cancer Center
Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Bevacizumab, Chemotherapy and Valproic Acid in Advanced Sarcomas
University of Iowa
Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma
University of Miami
VALFRID
Lund University Hospital
GAMA
Barretos Cancer Hospital
Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma
University of Virginia
PREVAIL
Lund University Hospital
Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies
H. Lee Moffitt Cancer Center and Research Institute
Phase I Study of Temozolomide, Valproic Acid and Radiation Therapy in Patients With Brain Metastases
H. Lee Moffitt Cancer Center and Research Institute
Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma
UNC Lineberger Comprehensive Cancer Center
DECIDER
University Hospital Freiburg
VAST
University of Utah
Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma
Chang Gung Memorial Hospital
Valproic Acid and Platinum-based Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma
Instituto do Cancer do Estado de São Paulo
Use of Hydralazine and Valproic Acid in Advanced Solid Tumor Malignancies
New Mexico Cancer Research Alliance
Differentiation Induction in Acute Myelogenous Leukemia
University of Bergen
Disease Stabilization in AML by Treatment With ATRA, Valproic Acid and Low-dose Cytarabine
University of Bergen
Treatment of Acute Leukemia Relapse After Allotransplantation
University of Bergen
Valproic Acid in Childhood Progressive Brain Tumors
Medical University of South Carolina
Metronomic
Miller Children's & Women's Hospital Long Beach
Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma
European Lung Cancer Working Party
A Phase II Study of Doxorubicin, Cyclophosphamide and Vindesine With Valproic Acid in Patients With Refractory or Relapsing Small Cell Lung Cancer After Platinum Derivatives and Etoposide
European Lung Cancer Working Party
Valproic Acid (Depakote ER) in Patients With Advanced Thyroid Cancer
University of California, San Francisco
Valproic Acid and Bevacizumab in Patients With Advanced Cancer
M.D. Anderson Cancer Center
Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma
H. Lee Moffitt Cancer Center and Research Institute
Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer
M.D. Anderson Cancer Center
Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor
M.D. Anderson Cancer Center